Preparation of Foot and Mouth Disease Trivalent Vaccine Type A, O, SAT2 and Determination of the Guinea Pig Protective Dose 50 (GPPD50)

Veterinary World- India

doi 10.14202/vetworld.2013.844-851

Full Text

Abstract

Available in

Categories

Date

September 23, 2013

Authors

Ehab El-Sayed Ibrahim

Wael Mossad Gamal El-Din

Amr Ismail Hassan Hassanin

Publisher

Veterinary World

Related search

Intra-Serotype SAT2 Chimeric Foot-And-Mouth Disease Vaccine Protects Cattle Against FMDV Challenge

Molecular Medicine

Infectious Diseases

Occupational Health

English

Production of Foot-And-Mouth Disease Virus SAT2 VP1 Protein

Applied Microbiology

English

Foot-And-Mouth Disease Virus Isolates: Candidate Strains for Trivalent Vaccine Development in Nigeria

African Journal of Microbiology Research

English

The Use of Culture Virus in the Preparation of Foot-And-Mouth Disease Vaccine

Epidemiology and Infection

Infectious Diseases

English

Using Chloroform as a Preservative for Trivalent Foot and Mouth Disease Vaccine in Comparison to Thiomersal

المجلة العربیة للعلوم الزراعیة

English

The Evolution and Phylodynamics of Serotype a and SAT2 Foot-And-Mouth Disease Viruses in Endemic Regions of Africa

Scientific Reports

Multidisciplinary

English

Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-And-Mouth Disease Virus in Pigs

Frontiers in Veterinary Science

English

Myocarditis Associated With Foot-And-Mouth Disease Virus Type O in Lambs

Veterinary Pathology

English

Effect of Vaccine Storage Temperatures and Dose Rate on Antibody Responses to Foot and Mouth Disease Vaccination in Cambodia

Veterinary Medicine and Science

English